US$ 22.69
nejm tirzepatide Weekly subcutaneous yields substantial weight loss in patients with or without diabetes. Weight reductions with higher doses approach those seen with bariatric surgery. https://t.co/YvcX73VCis @NEJM In the SURMOUNT-1 trial (published
Description
Levothyroxine is a long-term replacement for thyroid hormone in people with hypothyroidism
They are FDA-approved for managing type 2 diabetes and have been found effective in promoting weight loss in clinical trials

Some patients need volume primarily in the body of the upper lip

Ozempic (type 2 diabetes) tops out at 1.0 mg as the standard maintenance dose, with an optional step to 2.0 mg added in 2024
